Part-Time

Clinical Project Coordinator

Multiple Teams

Posted on 10/1/2025

Celerion

Celerion

1,001-5,000 employees

Global CRO for early-phase development

No salary listed

Remote in USA

Remote

This is a work-from-home, remote based position from any US geography.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor’s degree in a biomedical-related field, life sciences or equivalent field
  • Excellent oral and written communication skills in English
  • High level of organization, multi-tasking, judgement and analytical skills
  • Good time management skills to ensure adherence to timelines
  • Profound knowledge of Good Clinical Practice, 21 CRF Part 11, and other relevant regulatory requirements
  • Dedication to quality and reliability
  • Commitment to continuous training and knowledge sharing; proactively keeping up to date with procedural industry standards and international regulatory developments in clinical research
  • Ability to work well independently and as part of a team
  • Maintain confidentiality of Subject data and Sponsor/Client information
  • Computer literate
  • Pay attention to detail, be tactful, and diplomatic
  • Responds to client needs and is focused on client satisfaction
  • Willingness to learn and gain professional experience
Responsibilities
  • Support day-to-day management of studies, ensure within the Study Team that project/study tasks are delivered in time, within the budget, and according to Sponsor/Client expectations, in close cooperation with designated Project Team
  • Support the implementation and maintenance of studies; assist so that Sponsor and Investigator obligations are met and are in compliance with applicable regulatory requirements (including local law) as well as Good Clinical Practice
  • Support in document management (creation, review, collection, filing, forwarding) including submission documents, meeting minutes and Trial Master Files, from Pre-study Phase to Study Closure
  • Support (field) monitors by (but not limited to) preparing checklists, controlling completion status and timelines, updating relevant tracking sheets
  • Create, review, finalize, forward and file meeting minutes for all internal and external study-related meetings.
  • Support in Celerion process improvement
  • Support in-house in performing site feasibility and site qualification visits in order to select qualified sites
  • Support to prepare documents for Site Initiation Visits (SIVs), such as presentation slides
  • Support to prepare documents for Monitoring Visits
  • Support to prepare documents for Close-out Visits
  • Perform content review and quality checks of received documents
  • Cooperate with central TMF team to keep Trial Master File (TMF) up-to-date and track filed documents
  • Support query resolution in a timely manner
  • Support Serious Adverse Event (SAE) reporting according to study specifications
  • Support in document/review study status, site enrolment status
  • As a member of Celerion’s project teams, perform billable work in accordance with Celerion BCDs, SOPs and PGs, and within the relevant timelines
  • Interact with Sponsor/Client and participate in Sponsor/Client meetings as necessary
  • Participate and demonstrate proactive involvement in project/study meetings, internal project/study meetings, and other activities enhancing project progress
  • Participate in audits and inspections, including preparation and follow-up activities
  • Support Sponsor/Client in fulfilling their obligations with regard to submissions according to relevant regulatory requirements

Celerion is a global contract research organization focused on early-phase drug development. It supports pharmaceutical and biotech clients with trial design, feasibility, project management, clinical and medical monitoring, bioanalytical sciences, and regulatory affairs, all conducted under contract. Its work hinges on metabolite profiling using high-resolution mass spectrometry to inform development decisions. With 40+ years of experience and a global, integrated service network, Celerion aims to help clients bring safe, effective treatments to patients faster by delivering rigorous, timely research.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

N/A

Headquarters

Lincoln, Nebraska

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • THL Partners acquisition in 2026 funds geographic expansion and technology upgrades.
  • Jo Goodman’s 29-year expertise from AstraZeneca drives bioanalytical innovation.
  • CLIA certification enables high-complexity diagnostic testing on human specimens.

What critics are saying

  • Labnotes fails against Veeva, causing client exodus in 12-18 months.
  • THL debt strains cash flow, forcing service cuts in 6-12 months.
  • CMS revokes CLIA due to Lincoln lab overload in 18-24 months.

What makes Celerion unique

  • Celerion excels in HRMS metabolite profiling for early-phase drug development.
  • Labnotes software streamlines bioanalytical data management with advanced dataset tools.
  • GLP/GCP molecular testing including ELISpot and qPCR accelerates cell/gene therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

4%
PharmiWeb.com
May 7th, 2025
Celerion Launches Enhanced Version Of Labnotes Bioanalytical Data Management Software

LINCOLN, Neb.; May 6, 2025 (Business Wire) – Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors. The latest system enhancements streamline laboratory documentation and improve operational efficiency for users. The updated platform also offers advanced tools for handling and organizing large datasets, ensuring faster processing of reports and optimized database queries

Instrument Business Outlook
May 6th, 2025
Celerion Launches Enhanced Version of Labnotes Bioanalytical Data Management Software

Celerion launches enhanced version of labnotes bioanalytical data Management software.

Business Wire
Jun 5th, 2024
Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

Celerion was recognized as a CRO Leader in the quality, capabilities and reliability categories across two groups of respondents (small pharma and combined big and small pharma).

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion as Vice President of Bioanalytical Services

Celerion announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory.Post this

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion As Vice President Of Bioanalytical Services

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory. In her new role, Goodman will oversee the strategic direction and operational performance of the Lincoln bioanalytical laboratory, leveraging her extensive experience in pharmaceutical research and development to drive innovation and design and execute customized bioanalysis for clients’ needs. She will be responsible for delivering on Celerion’s bioanalytical promise of industry-leading science, stringent compliance, and speed of delivery. With over 29 years of experience in the pharmaceutical industry, Goodman brings a wealth of knowledge in regulated GxP and discovery bioanalysis for both in-house and outsourced activities. Prior to joining Celerion, she held positions of increasing responsibility at AstraZeneca, MedImmune, and GlaxoSmithKline. Additionally, Goodman is a recognized thought leader, having recently served as a member of the Expert Working Group (EWG) for ICH M10 Bioanalytical Guidance Development and is active in numerous non-profit industry consortia such as EBF, AAPS, and DMDG

INACTIVE